BOARD OF DIRECTORS

David Melville

Director

Peter Pedro

Director

Cynthia Mazareas

Director

Glen Giovanetti

Director

René Russo

Director

Mike Bonney

Director

Mike Tomsicek

Treasurer & Clerk

Rob Perez

Founder & Chairman

Tim Hunt

Clerk & Director

BOARD OF ADVISORS

Our Board of Directors and Board of Advisors have
committed to covering the administrative expenses of
the organization, so that every dollar we raise can be
put to work fighting poverty.

ABBIE CELNIKER

Third Rock Ventures
Partner

ABE CEESAY

Tiburio Therapeutics
Chief Executive Officer

ADAM GRIDLEY

Entera Bio
CEO

ADAM KOPPEL

Bain Capital Life Sciences
Managing Director

ADELENE PERKINS

Infinity Pharmaceuticals
President and CEO

ALI FATTAEY

Scipher Medicine
Head, Therapeutics Discovery & Development

ALICIA SECOR

Atalanta Therapeutics
President & CEO

ALISON LAWTON

Kaleido Biosciences
President & CEO

AMIR NASHAT

Polaris Partners
Partner

ANDREW HIRSCH

Agios Pharmaceuticals
Chief Financial Officer

ANKIT MAHADEVIA

Spero Therapeutics
CEO

BHARATT CHOWRIRA

PureTech Health
President

BILL HEIDEN

AMAG Pharmaceuticals
CEO

BILL HICKS

Mintz Levin
Members / Co-chair, Securities & Capital Markets Practice

BILL MCVICAR

Flex Pharma
CEO

BILL SIBOLD

Sanofi Genzyme
Senior Vice President

BJORN KOCH

UBS
Senior Vice President

BOB COUGHLIN

MassBio
President & CEO

BRIAN GOFF

Alexion Pharmaceuticals

Chief Commercial and Global Operations Officer

BRIAN JOHNSON

MassMEDIC
President

BRUCE BOOTH

Atlas Ventures
Partner

BRUCE JACOBS

Kymera Therapeutics

CFO

BRYAN PEREIRA

Visterra

CEO

CHERIE MYATT

The CM Group

Owner & Founder

CHIP CLARK

Genocea
President and CEO

CHRIS GABRIELI

Biotech VC (Retired)

CHRIS GUIFFRE

Pear Therapeutics
CFO & COO

CHRISTOPH WESTPHAL

Longwood Fund
General Partner

CISSY YOUNG

Russell Reynolds
Managing Director

COLIN HILL

GNS Healthcare
CEO, Chairman and Co-Founder

Cynthia Mazareas

WilmerHale

Partner

DANIEL GEFFKEN

Danforth Advisors
Managing Director

DANIEL LYNCH

bluebird bio
Chairman

DAVE MELLO

The Richmond Group
President

DAVID LUCCHINO

Frequency Therapeutics
CEO

DAVID MEEK

FerGene
President & CEO

DAVID MEEKER

KSQ Therapeutics

President & CEO

David Melville

The Bowdoin Group

CEO

DEE DEE DEMAN

Bench International
Chairman & CEO

DEVAL PATRICK

DONNA HIGGINS

The Higgins Group
President & CEO

DONNA LAVOIE

LavoieHealthScience

CEO

DOUG INGRAM

Sarepta

CEO

DOUGLAS FAMBROUGH

Dicerna
CEO

DOUGLAS PAGAN

Dicerna Pharmaceuticals
CFO

ED KAYE

Stoke Therapeutics

CEO

EDDIE MARTUCCI

Akili Interactive
CEO

EDWARD DOWNEY

Plimouth Rock Risk Consulting
Principal

ELAN EZICKSON

Scholar Rock, Inc
COO and Head, Corporate Development (Retired)

ELISABET DE LOS PINOS

Aura Biosciences
CEO

ELIZABETH WAGNER

Constant Pharmaceuticals
COO

ERIC KIMBLE

Entasis Therapeutics

Chief Commercial Officer

ERIC LANDER

Broad Institute

President & Founding Director

Eric Shaff

Seres Therapeutics

President & CEO

FRANK THOMAS

Orchard Therapeutics
CFO & CBO

GEOFFREY MCDONOUGH

Generation Bio
President & CEO

GERRY BRUNK

Lumira VC Managing Director

Glen Giovannetti

EY

Global Biotechnology Leader

GREG ERMAN

EmpiraMed, Inc.
CEO

GREG MADISON

Melt Pharmaceuticals
CEO

HALLEY GILBERT

Ironwood Pharmaceuticals
Senior Vice President & Chief Legal Officer

HILARY MALONE

Integral Therapeutics

COO

HUGH COLE

Jounce Therapeutics
Chief Business Officer & Head of Corporate Development

IAN SANDERSON

Boston Pharmaceuticals

Chief Financial Officer

IMRAN BABAR

Cydan II
Chief Business Officer

IVANA MAGOVCEVIC-LIEBISCH

Ipsen
EVP & Chief Business Officer

IYA KHALIL

Novartis

Global Head of the Al Innovation Center

JAMES FOSTER

Charles River Labs
Chairman, President & CEO

JEAN GEORGE

Lightstone Ventures
General Partner

JEB KEIPER

Nimbus Therapeutics
CEO

JEFF LEERINK

SVB Leerink
CEO

JEFF LEIDEN

Vertex
Executive Chairman

JEFFREY HEMMAN

PwC
Partner

JIGAR RAYTHATHA

Constellation Pharmaceuticals
CEO

JILL MILNE

Catabasis Pharmaceuticals

President & Chief Executive Officer

JIM GERAGHTY

Experienced Board Director and Chair

JOE FARMER

Akrevia Therapeutics
COO

JOE VITTIGLIO

AMAG Pharmaceuticals
Executive Vice President and General Counsel

JOE VON RICKENBACH

Parexel
Co-Founder & Chairman

JOEP MUIJRERS

PureTech Health
Chief Financial Officer

JOHN FREY

First Republic Bank
Managing Director, Foreign Exchange

JOHN GLASSPOOL

Anthos Therapeutics
CEO

JOHN MARAGANORE

Alnylam
CEO

Jose Trevejo

SmartPharm Therapeutics
CEO & Co-Founder

Joshua Boger

Vertex Pharmaceuticals

Founder & CEO (Former)

KATIE MCCARTHY

Halloran Consulting Group
Managing Director

KATIE MCCARTHY

Halloran Consulting Group

Managing Director

KEVIN BITTERMAN

Atlas Ventures
Partner

KURT GRAVES

Intarcia
Chairman, President and CEO

KUSH PARMAR

5AM Ventures
Managing Partner

LAURENCE REID

Decibel Therapeutics

CEO

LESLIE ORNE

Trinity
Senior Partner

LESLIE WILLIAMS

Ocular Therapeutics Board Member

MARC BEER

Renovia
CEO

MARIAN NAKADA

J&J
Vice President, Venture Investments

MARK BAMFORTH

Arranta Bio
President & CEO

MARK LEVIN

Third Rock Ventures
Partner

MARY THISTLE

Bill & Melinda Gates Medical Research Institute
Chief of Staff

MAURA HODGE

KPMG
Partner

MICHAEL HANEWICH

Silicon Valley Bank
Managing Director

MICHAEL HEFFERNAN

Collegium Pharmaceuticals
Chairman

MICHAEL MAGUIRE

Putnam Investments
Healthcare Analyst

MICHEL LAGARDE

Thermo Fisher Scientific

Executive Vice President

MICHEL VOUNATSOS

Biogen
CEO

MICHELLE DIPP

Biospring Partners Co-Founder and Managing Partner

MIKE BONNEY

Kaleido Biosciences
Executive Chair

MIKE GRAY

Imara
Chief Financial & Chief Operating Officer

MIKE O’HARA

Deloitte
Partner

Mike Tomsicek

CRISPR Therapeutics

Chief Financial Officer

MITCH BLOOM

Goodwin Procter LLP
Partner

NABIHA SAKLAYEN

Cellino Biotech

Co-Founder & CEO

NANCY SIMONIAN

Syros Pharmaceuticals
CEO

NEAL DUNN

Trinity
Partner

NERISSA KREHER

Tiburio Therapeutics

Chief Medical Officer

NICK GALAKATOS

Blackstone
Senior Managing Director

OTELLO STAMPACCHIA

Omega Funds
Founder

PARIS PANAYIOTOPOULOS

Clarus Funds
Operating Partner

PATRICIA ANDREWS

Boston Biomedical
CEO

PAUL BURGESS

Translate Bio

Chief Legal Officer and Chief Operating Officer

Paul Clancy

Alexion

Executive Vice President (Former)

PAUL ENDERLE

Baycross Capital Group, LLC
Managing Director

PAULA RAGAN

X4 Pharmaceuticals

CEO & President

PENNY HEATON

Bill & Melinda Gates Medical Research Institute
CEO

PETER BARRETT

Atlas Ventures
Partner

PETER LATHAM

Latham BioPharm Group
CEO

Peter Pedro

Marsh & McLennan Agency

Executive Vice President

PIERRE JACQUET

L.E.K. Consulting
Managing Director & Partner

PRAVEEN TIPIRNENI

Morphic Therapeutic
CEO

RAJEEV VENKAYYA

Takeda
President, Global Vaccines Business Unit

RAMI LEVIN

Saniona CEO

Rene Russo

Akrevia

CEO

RICH ALDRICH

Longwood
General Partner

RICHARD PAULSON

Ipsen North America CEO

Rob Perez

General Atlantic

Operating Partner

ROBERT FORRESTER

EQRx CXO

ROBERT URBAN

Head of Johnson & Johnson Innovation

RON COOPER

Albireo Pharma
President & CEO

ROSANNA KAPELLER

Google Ventures
Entrepreneur in Residence

ROY HIRSHLAND

T3 Advisors
CEO, Co-Founder

RUSSELL BARTLETT

Alex Brown
Vice President

RUSSELL HERNDON

Hydra Biosciences
President

SAMANTHA TRUEX

Quench Bio
CEO

SCOTT CHAMBERLIN

Cambridge Trust Company
Senior Vice President & Head of Innovation Banking

STEPHANE BANCEL

Moderna Therapeutics
CEO

STEVE HOLTZMAN

Decibel Therapeutics
President & CEO (Retired)

STEVEN DICKMAN

CBT Advisors

Owner

STUART CABLE

Goodwin Procter LLP
Partner

STUART RANDLE

SUSAN NEMETZ

The NemetzGroup
Principal

TED MYLES

Scholar Rock
CFO & Head of Business Operations

THOMAS CAREY

Perspective Group LLC
Founder & Managing Partner

THOMAS DESROSIER

Seres Therapeutics
Executive Vice President & Chief Legal Officer

TIM EHRLICH

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian

Partner

TIM HUNT

Editas Medicine

Senior Vice President, Corporate Affairs

TIMOTHY THOMPSON

TOM ANDREWS

Alexandria Real Estate Equities
Executive Vice President

TONY COLES

Cerevel Therapeutics CEO

TRAVIS MCCREADY

Puddingstone Consulting Consultant & Advisor

WENDY ERLER

Alexion
VP, Head of STAR Patient Insights and Advocacy

ZOLTAN CSIMMA

Senior Biotech Executive

We are also extremely grateful to the generous companies who have provided pro bono services to help in the fight against poverty in greater Boston, including: